Core Insights - The company reported a revenue of RMB 862 million for the six months ending June 30, 2025, with a gross profit of RMB 550 million, representing a year-on-year increase of 3.9% [1] - The company achieved a net profit attributable to shareholders of RMB 27.913 million, marking a turnaround from a loss in the previous year, with earnings per share of RMB 0.06 [1] Company Overview - The company is a leading medical group in China specializing in hair medical services, offering a comprehensive range of services including hair transplantation, medical hair care, routine maintenance, and other related services [1] - The company has established a full industry chain brand matrix centered around "Yonghe Medical," which includes specialized brands such as "Yonghe Hair Transplant," "Shiyunxun" for medical hair care, "Yonghe Fazhichu" for women's aesthetic hair transplantation, and "Hafada" for medical wigs [1] Market Presence - As of June 30, 2025, the company operates 63 hair transplant medical institutions across 61 cities in China, making it the largest and most widely covered chain of hair medical services in the country [1] - The company served a total of 64,845 consumers during the six-month period ending June 30, 2025 [1]
雍禾医疗(02279)发布中期业绩 股东应占溢利2791.3万元 同比扭亏为盈